A listed University of Leeds spinout which has fought for survival in recent months is to deepen its investigation into the actions of former directors. Tissue Regenix Group, a regenerative medical devices company, recently left the London Stock Exchange after two decades following a chaotic 2025 which almost saw it enter insolvency. In December the … Continue reading MedTech uncovers ‘serious corporate governance concerns’